Condition
Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer|Uterine Cancer|Mesotheliomas|Gastrointestinal Cancers|Cervical Cancer
Estimated Enrollment: 200
Age Group: 18 Years to 75 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: HIPEC
Study First Received: December 22, 2014
Last Updated: January 30, 2017
Estimated Primary Completion Date: January 2018
Primary Outcome Measures:
measure treatment response to HIPEC and tumor debulking|Toxicity Monitoring
Sponsors and Collaborators:
Bay Area Gynecology Oncology
Website Link: https://ClinicalTrials.gov/show/NCT02349958
